Skip to content

Clinical trials

Phase 2 Biliary Tract Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Biliary Tract Neoplasms Phase: Phase 2 Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20161
20171
20181
20191
20201
20212
20223
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting3
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AIO-Studien-gGmbH2
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest2
AstraZeneca1
Basilea Pharmaceutica1
Bayer1
Boehringer Ingelheim1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Fore Biotherapeutics1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Biliary Tract Neoplasms14
Cholangiocarcinoma6
Colorectal Neoplasms4
Breast Neoplasms3
Gallbladder Neoplasms3
Ovarian Neoplasms3
Bile Duct Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Gastrointestinal Stromal Tumors2
Glioma2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.